Gamma-oryzanol,
does it really help with Cholesterol, menopause, autonomic nervous system?
research showsGamma-oryzanol has a history of use in Japan, China, and elsewhere for menopausal or autonomic-nervous symptoms and for lipid improvement, but verifiable human RCT and meta-analysis evidence by modern standards is very limited. Evidence for rice bran oil or phytosterols cannot be transferred directly to gamma-oryzanol as a single ingredient.
ads claimAdvertising ranges widely across 'autonomic nervous system stabilization,' 'menopause,' 'cholesterol,' 'rice-bran antioxidant,' and even 'male hormones.' Compared with ingredient background and traditional use, clinical trials are weak.
Useful facts when choosing a product
- Gamma-oryzanol is not a single substance but a mixture of several ferulate esters.
- Rice bran oil, brown rice, phytosterols, and gamma-oryzanol capsules should have their evidence separated.
- Long-term high-dose safety data are limited.
- When combined with or substituted for menopausal-symptom treatments, clinician judgment is needed.
What the research actually shows
Gamma-oryzanol is a mixture of ferulic acid esters of phytosterols/triterpenoids, and there are many composition-analysis, antioxidant, and animal studies. Cholesterol evidence is easily mixed with studies in the context of whole rice bran oil or phytosterols, while menopause and autonomic-nervous claims center on older use experience, making modern RCT evidence difficult to specify. For sports and testosterone uses, existing reviews summarize that they found no supporting evidence.
Why this is classified as ?
Preclinical data and use experience alone cannot justify C or higher; conversely, the pool of verifiable human studies is insufficient to conclude D/F. Methodologically, this is kept as Judgment deferred.
Counterpoint. If modern placebo-controlled RCTs are identified, cholesterol, menopause, and autonomic nervous system should each be reassessed separately.
Rejudgment record. Draft — Insufficient confirmation of direct human RCTs/meta-analyses for cholesterol, menopause, and autonomic-nervous-system claims
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Xu Z, Godber JS. 1999 | Compositional analysis study | Academic | Gamma-oryzanol components | Identified the main components of gamma-oryzanol in rice bran oil. | Background | |
| Williams M. 2006 | Sports-supplement review | Academic | Exercise-performance and hormone claims | Summarized that evidence supporting the ergogenic/testosterone claims of gamma-oryzanol was insufficient. | Supporting |
Receipt — 3 References
Every cited source was opened and checked against the live page on 2026-07-09.
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-09 · Corrections: none
Cite this verdict
[Chamgap] Gamma-oryzanol × cholesterol, menopause, autonomic nervous system — Evidence Grade ?. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/womens/gamma-oryzanol-cholesterol-menopause-autonomic/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.